Improved production of class I phosphatidylinositol 4,5-bisphosphate 3-kinase

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Biology

Background:

• Phosphatidylinositol 4,5-bisphosphate 3-kinases (PI3K) are critical enzymes involved in fundamental cellular processes.
• The PI3K pathway is frequently dysregulated in human cancers, making PI3K a significant therapeutic target.
• Previous efforts to produce PI3K proteins for research have faced challenges with yield and purity.

Purpose of the Study:

• To optimize the production of stable and pure PI3K protein isoforms.
• To increase the yield of specific PI3K subunits, particularly p110α/p85α and p110α.
• To establish protocols for producing other PI3K isoforms (β and δ) for further study.

Main Methods:

• Employing modified expression strategies, including enhanced solubility tags and novel expression modalities.
• Developing and optimizing a purification protocol with specific buffer conditions.
• Applying these methods to achieve significant increases in protein yield for PI3K subunits.

Main Results:

• Achieved a 40-fold increase in yield for the p110α/p85α complex.
• Obtained a 3-fold increase in yield for the p110α subunit.
• Successfully produced comparable constructs for PI3K β and δ isoforms.

Conclusions:

• The developed methods significantly enhance the yield and purity of PI3K proteins.
• Increased protein availability facilitates downstream high-throughput drug discovery efforts targeting the PIK3 family.
• This work provides a foundation for further investigation into PI3K-related cellular functions and therapeutic strategies.